These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 8468432

  • 1. RIMA--a new concept in the treatment of depression with moclobemide.
    Amrein R, Hetzel W, Stabl M, Schmid-Burgk W.
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):123-32. PubMed ID: 8468432
    [Abstract] [Full Text] [Related]

  • 2. Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo.
    Versiani M, Nardi AE, Figueira IL, Stabl M.
    Acta Psychiatr Scand Suppl; 1990 Jan; 360():24-8. PubMed ID: 2123366
    [Abstract] [Full Text] [Related]

  • 3. Moclobemide--placebo-controlled trials.
    Silverstone T.
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):133-6. PubMed ID: 8468433
    [Abstract] [Full Text] [Related]

  • 4. RIMA: a safe concept in the treatment of depression with moclobemide.
    Amrein R, Hetzel W, Stabl M, Schmid-Burgk W.
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():7-11. PubMed ID: 1394030
    [Abstract] [Full Text] [Related]

  • 5. The efficacy of reversible monoamine oxidase inhibitors in depressive illness.
    Roth M, Guelfi JD.
    Can J Psychiatry; 1992 Sep; 37 Suppl 1():18-24. PubMed ID: 1394027
    [Abstract] [Full Text] [Related]

  • 6. A risk-benefit assessment of moclobemide in the treatment of depressive disorders.
    Norman TR, Burrows GD.
    Drug Saf; 1995 Jan; 12(1):46-54. PubMed ID: 7741983
    [Abstract] [Full Text] [Related]

  • 7. Moclobemide: therapeutic use and clinical studies.
    Bonnet U.
    CNS Drug Rev; 2003 Jan; 9(1):97-140. PubMed ID: 12595913
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of reversible inhibitors of monoamine oxidase-A in various forms of depression.
    Lecrubier Y, Guelfi JD.
    Acta Psychiatr Scand Suppl; 1990 Jan; 360():18-23. PubMed ID: 2248063
    [Abstract] [Full Text] [Related]

  • 9. Double-blind comparison of moclobemide, imipramine and placebo in depressive patients.
    Ucha Udabe R, Márquez CA, Traballi CA, Portes N.
    Acta Psychiatr Scand Suppl; 1990 Jan; 360():54-6. PubMed ID: 2123367
    [Abstract] [Full Text] [Related]

  • 10. Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states.
    Stabl M, Biziére K, Schmid-Burgk W, Amrein R.
    J Neural Transm Suppl; 1989 Jan; 28():77-89. PubMed ID: 2677244
    [Abstract] [Full Text] [Related]

  • 11. An Australian multicentre study of moclobemide versus amitriptyline in the treatment of depression.
    Evans L, George T, O'Sullivan B, Mitchell P, Johnson G, Adena M.
    Aust N Z J Psychiatry; 1992 Sep; 26(3):454-8. PubMed ID: 1417632
    [Abstract] [Full Text] [Related]

  • 12. The role of moclobemide in endogenous depression: a survey of recent data.
    Woggon B.
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):137-9. PubMed ID: 8468434
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic efficacy of antidepressants in agitated anxious depression--a meta-analysis of moclobemide studies.
    Delini-Stula A, Mikkelsen H, Angst J.
    J Affect Disord; 1995 Oct 09; 35(1-2):21-30. PubMed ID: 8557884
    [Abstract] [Full Text] [Related]

  • 14. Moclobemide, imipramine and placebo in the treatment of major depression.
    Versiani M, Nardi AE, Mundim FD, Alves A, Schmid-Burgk W.
    Acta Psychiatr Scand Suppl; 1990 Oct 09; 360():57-8. PubMed ID: 2248073
    [Abstract] [Full Text] [Related]

  • 15. Switch in treatment from tricyclic antidepressants to moclobemide: a new generation monoamine oxidase inhibitor.
    Dingemanse J, Kneer J, Fotteler B, Groen H, Peeters PA, Jonkman JH.
    J Clin Psychopharmacol; 1995 Feb 09; 15(1):41-8. PubMed ID: 7714227
    [Abstract] [Full Text] [Related]

  • 16. Tyramine pressor response with moclobemide--a reversible monoamine oxidase inhibitor.
    Tiller JW, Maguire KP, Davies BM.
    Psychiatry Res; 1987 Nov 09; 22(3):213-20. PubMed ID: 3432450
    [Abstract] [Full Text] [Related]

  • 17. Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group.
    J Affect Disord; 1993 Jun 09; 28(2):105-16. PubMed ID: 8354766
    [Abstract] [Full Text] [Related]

  • 18. Interaction between moclobemide and oral tyramine in depressed patients.
    Burgess CD, Mellsop GW.
    Fundam Clin Pharmacol; 1989 Jun 09; 3(1):47-52. PubMed ID: 2714732
    [Abstract] [Full Text] [Related]

  • 19. Moclobemide. An update of its pharmacological properties and therapeutic use.
    Fulton B, Benfield P.
    Drugs; 1996 Sep 09; 52(3):450-74. PubMed ID: 8875133
    [Abstract] [Full Text] [Related]

  • 20. Moclobemide versus placebo in the treatment of depression: a multicentre study in Belgium.
    Botte L, Gilles C, Evrard JL, Mesters P, Wolfrum C, Berger M, Hellstern K, Ward J.
    Acta Psychiatr Scand Suppl; 1990 Sep 09; 360():42. PubMed ID: 2248066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.